Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-20 of 120

Sort by

Sort Order Select

Journal Articles

Moura PL, Nannya Y, Aliouat A, et al. Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells. Blood Neoplasia. 2024;1(2):100011.

Blood Neoplasia (2025) 2 (2): 100088.

https://doi.org/10.1016/j.bneo.2025.100088

Published: 2025

Journal Articles

Uemura Y, Yamamoto M, Ishimura M, et al. JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia . 2025;2(1):100053.

Blood Neoplasia (2025) 2 (2): 100084.

https://doi.org/10.1016/j.bneo.2025.100084

Published: 2025

Journal Articles

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls

Rose Laflamme, Véronique Lisi, Josée Hébert, Guy Sauvageau, Sébastien Lemieux, Vincent-Philippe Lavallée, Guillaume Lettre

Blood Neoplasia 100118.

https://doi.org/10.1016/j.bneo.2025.100118

Published: 2025

Includes: Supplemental data

Journal Articles

PPARγ-induced Upregulation of Fatty Acid Metabolism Confers Resistance to Venetoclax and Decitabine Therapy in AML.

Kotoko Yamatani, Tatsuro Watanabe, Kaori Saito, Abdullah Khasawneh, Abhishek Maiti, Zhihong Zeng, Kala Hayes, Shinya Kimura, Courtney D. DiNardo, Xiaoping Su, Shuko Nojiri, Yasushi Okazaki, Michael Andreeff, Marina Konopleva, Yoko Tabe

Blood Neoplasia 100121.

https://doi.org/10.1016/j.bneo.2025.100121

Published: 2025

Includes: Supplemental data

Journal Articles

Outcomes and factors influencing survival in patients with diffuse large B cell lymphoma: a population-based analysis

Inna Y Gong, Michael Crump, Anca Prica, Andrew Calzavara, Ning Liu, Tiana Kordbacheh, Danielle Rodin, David Hodgson, Lee Mozessohn, Matthew Cheung, John Kuruvilla

Blood Neoplasia 100117.

https://doi.org/10.1016/j.bneo.2025.100117

Published: 2025

Includes: Supplemental data

Journal Articles

NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation

Madhavi D. Senagolage, Hunter Z. Blaylock, Saira Khan, Sarah J. Skuli, Martin P. Carroll, Megan E. McNerney

Blood Neoplasia 100119.

https://doi.org/10.1016/j.bneo.2025.100119

Published: 2025

Includes: Supplemental data

Journal Articles

An Antibody-Drug Conjugate Targeting VpreB1 for the Treatment of B-cell Acute Lymphoblastic Leukemia

Peter M. Gordon, Robin L. Williams, Jason Ostergaard, Keegan C. Lee, Hannah N. Bui, Joseph M. Muretta, Bridget S. Wilson, Thomas Beder, Claudia D. Baldus, Luke Lambert, Benjamin E. Deonovic, Timothy Singleton, Sarah K. Tasian, Stuart S. Winter

Blood Neoplasia 100120.

https://doi.org/10.1016/j.bneo.2025.100120

Published: 2025

Includes: Supplemental data

Journal Articles

Real world performance of the CALGB 10403 regimen in young adults in the United States

Brandon DaSilva, Alicia Darwin, Amy Zhang, Rutu D. Vyas, Kathryn Russell, Jason S. Gilbert, Virginia Tan, Susan Feldt, Hannah Johnston, Emily C Liang, Adam S. DuVall, Michaela Liedtke, Wendy Stock, Ryan D. Cassaday, Marc Schwartz, Jessica T. Leonard, Lori S. Muffly, Marlise R. Luskin

Blood Neoplasia 100111.

https://doi.org/10.1016/j.bneo.2025.100111

Published: 2025

Includes: Supplemental data

Journal Articles

A Comparative Assessment of Molecular-Based Prognostic Models in CMML

Luis E. Aguirre, Najla Al Ali, Somedeb Ball, Akriti G. Jain, David Sallman, Andrew Kuykendall, Alison R. Walker, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, Rami S. Komrokji

Blood Neoplasia 100116.

https://doi.org/10.1016/j.bneo.2025.100116

Published: 2025

Includes: Supplemental data

Journal Articles

Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT

Erin A. Dean, Arkaprava Roy, Rick Y. Lin, Raad Z. Gharaibeh, Derek M. Li, Josee Gauthier, Christian Jobin, John R. Wingard

Blood Neoplasia 100114.

https://doi.org/10.1016/j.bneo.2025.100114

Published: 2025

Includes: Supplemental data

Journal Articles

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Blood Neoplasia 100110.

https://doi.org/10.1016/j.bneo.2025.100110

Published: 2025

Includes: Supplemental data

Journal Articles

Prognostic impact of Extranodal Disease on PET/CT in Follicular Lymphoma: Results from a Validation Study with ECOG 2408

Frederique St-Pierre, Stephen M. Broski, Zequn Sun, Masha Kocherginsky, Betsy Laplant, Matthew J. Maurer, Andrew Quon, Lucia Baratto, Hatice Savas, Lale Kostakoglu, Jane N. Winter, Thomas E. Witzig, Brad Kahl, Andrew M. Evens, Leo I. Gordon

Blood Neoplasia 100113.

https://doi.org/10.1016/j.bneo.2025.100113

Published: 2025

Includes: Supplemental data

Journal Articles

Temporal clonal relatedness between myeloid neoplasm and nodal T follicular helper cell lymphoma: a retrospective study

Mingfei Yan, Robert Stuver, Kai Shiang Lin, William T. Johnson, Steven M. Horwitz, Ahmet Dogan, Wenbin Xiao

Blood Neoplasia 100112.

https://doi.org/10.1016/j.bneo.2025.100112

Published: 2025

Includes: Supplemental data

Journal Articles

Tagraxofusp, a CD123-Targeted Therapy, for Chronic Myelomonocytic Leukemia: Final Results of a Phase 1/2 Study

Mrinal M. Patnaik, Haris Ali, Eunice S. Wang, Abdulraheem Yacoub, James M. Foran, Vikas Gupta, Gary J. Schiller, Don Ambrose Stevens, Moshe Talpaz, Sarah Wall, Terra L Lasho, Abhishek A. Mangaonkar, Talha Badar, Ross Lindsay, Antonio Galleu, Ira Gupta, Naveen Pemmaraju, Guillermo Garcia-Manero

Blood Neoplasia 100115.

https://doi.org/10.1016/j.bneo.2025.100115

Published: 2025

Includes: Supplemental data

Journal Articles

Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions

Tamara Westover, Michael P. Walsh, Sherif Abdelhamed, Emily Xiong, Jing Ma, Guangchun Song, Melvin E. Thomas, III, Masayuki Umeda, Jamie L. Maciaszek, Jasmine C. Wong, Astrid Wintering, Lu Wang, Peter D. Emanuel, Mignon L. Loh, Sarah K. Tasian, Elliot Stieglitz, Jason R. Schwartz, Kevin M. Shannon, Jeffery M. Klco

Blood Neoplasia (2025) 2 (2): 100093.

https://doi.org/10.1016/j.bneo.2025.100093

Published: 2025

Includes: Supplemental data

Journal Articles

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant

Brian Cuzzo, Maegan Ford, Saagar Jain, Hua-Jay Cherng, Evelyn Orlando, Patrick Gould, Amy Song, Benjamin May, Yuxuan Chen, Govind Bhagat, Andrew H. Lipsky, Barbara Pro, Jennifer E. Amengual

Blood Neoplasia (2025) 2 (2): 100094.

https://doi.org/10.1016/j.bneo.2025.100094

Published: 2025

Journal Articles

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14) +

Sae Matsuoka, Naoki Osada, Hirokazu Kubota, Ko Kikuzato, Hiroo Koyama, Takeshi Sonoda, Akiko Idei, Minoru Yoshida, Masaki Kikuchi, Takashi Umehara, Chiduru Watanabe, Teruki Honma, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Hideki Nakasone, Jiro Kikuchi, Yusuke Furukawa

Blood Neoplasia (2025) 2 (2): 100091.

https://doi.org/10.1016/j.bneo.2025.100091

Published: 2025

Includes: Supplemental data

Journal Articles

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Blood Neoplasia (2025) 2 (2): 100089.

https://doi.org/10.1016/j.bneo.2025.100089

Published: 2025

Includes: Supplemental data

Journal Articles

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Hannah Kunstek, Janneke Kieviet, Caroline Lindemans, Coco de Koning, Stefan Nierkens

Blood Neoplasia (2025) 2 (2): 100090.

https://doi.org/10.1016/j.bneo.2025.100090

Published: 2025

Journal Articles

Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4 + T cells in MDS.

Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Kristopher M. Attwood, Joseph B. Kuechle, Prashant K. Singh, Jianmin Wang, Michael J. Nemeth

Blood Neoplasia 100106.

https://doi.org/10.1016/j.bneo.2025.100106

Published: 2025

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Moura PL, Nannya Y, Aliouat A, et al. Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells. Blood Neoplasia. 2024;1(2):100011.

Uemura Y, Yamamoto M, Ishimura M, et al. JAK1/2 inhibitor ruxolitinib for the treatment of systemic chronic active Epstein-Barr virus disease: a phase 2 study. Blood Neoplasia . 2025;2(1):100053.

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls

PPARγ-induced Upregulation of Fatty Acid Metabolism Confers Resistance to Venetoclax and Decitabine Therapy in AML.

Outcomes and factors influencing survival in patients with diffuse large B cell lymphoma: a population-based analysis

NAMPT haploinsufficiency is a collateral lethal therapeutic vulnerability in high-risk myeloid malignancies with TP53 inactivation

An Antibody-Drug Conjugate Targeting VpreB1 for the Treatment of B-cell Acute Lymphoblastic Leukemia

Real world performance of the CALGB 10403 regimen in young adults in the United States

A Comparative Assessment of Molecular-Based Prognostic Models in CMML

Gut Faecalibacterium abundance in patients with plasma cell disorders is associated with survival after autologous HSCT

Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia

Prognostic impact of Extranodal Disease on PET/CT in Follicular Lymphoma: Results from a Validation Study with ECOG 2408

Temporal clonal relatedness between myeloid neoplasm and nodal T follicular helper cell lymphoma: a retrospective study

Tagraxofusp, a CD123-Targeted Therapy, for Chronic Myelomonocytic Leukemia: Final Results of a Phase 1/2 Study

Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions

Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplant

Discovery of a novel class NSD2 inhibitor for multiple myeloma with t(4;14) +

Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms

Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation

Checkpoint immunotherapy is associated with preferential activation of tumor-antigen specific CD4 + T cells in MDS.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only